We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Agilent Technologies Introduces First Commercial GC/MS Metabolite Library

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Agilent Technologies Inc. has introduced the Agilent Fiehn Metabolomics Retention Time Locked (RTL) Library for gas chromatography/mass spectrometry (GC/MS). It is said to be the first commercially available mass spectral library for the identification of metabolites found in metabolomic studies.

The Agilent Fiehn Metabolomics RTL Library was developed by Agilent in conjunction with Oliver Fiehn, Ph.D., a preeminent metabolomics scientist.

In addition to providing a high degree of confidence in metabolite identification, the library contains pre-programmed methods to further facilitate analyses, according to Agilent.

“Because this is a commercial offering by Agilent, researchers can be confident in the results they get from data searches,” said Steve Fischer, Agilent product manager, Metabolomics.

“Also, the library is retention indexed, which will facilitate comparisons with private metabolite libraries. This is the most complete metabolite library commercially available, and users can be confident that this tool will remain up-to-date for years to come.”

Results from data processing using the Agilent Fiehn library can be imported into Agilent’s GeneSpring MS bioinformatics software for mass spectrometry, enabling the comparison of large data sets for discovery of metabolite biomarkers.

The library complements the Agilent METLIN personal metabolite database used for metabolomics analysis by liquid chromatography/mass spectrometry, developed in 2007 exclusively for Agilent customers in cooperation with Mass Consortium Corp.